I agree that this site is using cookies. You can find further informations here.
X
Sunagawa, Shawnalyn W.
17  results:
Search for persons X
?
1

Use of a beta-lactam graded challenge process for inpatient..:

Sunagawa, Shawnalyn W. ; Bergman, Scott J. ; Kreikemeier, Emily...
Frontiers in Allergy.  4 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

2021 CDC STI treatment guideline compliance post-implementa..:

Sunagawa, Shawnalyn W. ; Collins, Olivia M. ; Lewis, Terese...
The American Journal of Emergency Medicine.  72 (2023)  - p. 198-200 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Long-Acting Cabotegravir/Rilpivirine Concentrations in Comb..:

Sunagawa, Shawnalyn W ; Havens, Joshua P ; Podany, Anthony...
Open Forum Infectious Diseases.  10 (2023)  12 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Rise of the (possible) resistance: a review of susceptibili..:

Sunagawa, Shawnalyn W. ; Christopherson, Catherine ; Bergman, Scott J....
Antimicrobial Stewardship & Healthcare Epidemiology.  3 (2023)  1 - p. , 2023
Link: https://doi.org/10.1017/..
 
?
5

Serious Adverse Events and Laboratory Monitoring Regimens f..:

Sunagawa, Shawnalyn W ; Arduser, Sarah ; Miller, Molly M...
Open Forum Infectious Diseases.  10 (2023)  12 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

Targeted Immuno-Antiretroviral to Promote Dual Protection a..:

Mandal, Subhra ; Sunagawa, Shawnalyn W. ; Prathipati, Pavan Kumar...
Nanomaterials.  12 (2022)  11 - p. 1942 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Turmeric-Associated Drug-Induced Liver Injury:

Sunagawa, Shawnalyn W. ; Houlihan, Conor ; Reynolds, Brandon...
ACG Case Reports Journal.  9 (2022)  12 - p. e00941 , 2022
Link: https://doi.org/10.14309..
 
?
8

Use of a beta-lactam graded challenge process for inpatient..:

Sunagawa, Shawnalyn W ; Bergman, Scott J ; Kreikemeier, Emily...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425280/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Targeted Immuno-Antiretroviral to Promote Dual Protection a..:

Mandal, Subhra ; Sunagawa, Shawnalyn W ; Prathipati, Pavan Kumar...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183115/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

101. Serious Adverse Event Rates for Cefazolin and Ceftriax..:

Sunagawa, Shawnalyn ; Arduser, Sarah ; Miller, Molly M...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Rise of the (possible) resistance: a review of susceptibili..:

Shawnalyn W. Sunagawa ; Catherine Christopherson ; Scott J. Bergman...
https://www.cambridge.org/core/product/identifier/S2732494X23004643/type/journal_article.  , 2023
Link: https://doi.org/10.1017/..
 
?
12

Use of a beta-lactam graded challenge process for inpatient..:

Shawnalyn W. Sunagawa ; Scott J. Bergman ; Emily Kreikemeier...
https://www.frontiersin.org/articles/10.3389/falgy.2023.1161683/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

Targeted Immuno-Antiretroviral to Promote Dual Protection a..:

Subhra Mandal ; Shawnalyn W. Sunagawa ; Pavan Kumar Prathipati...
Synthesis, Interfaces and Nanostructures.  , 2022
Link: https://doi.org/10.3390/..
 
?
14

Targeted Immuno-Antiretroviral to Promote Dual Protection a..:

Subhra Mandal ; Shawnalyn W. Sunagawa ; Pavan Kumar Prathipati...
https://www.mdpi.com/2079-4991/12/11/1942.  , 2022
Link: https://doi.org/10.3390/..
 
?
15

162. The Genotypic Antibiogram: Using Results of Gram-Negat..:

Sunagawa, Shawnalyn ; Tigh, Jeremy E ; Okada, Ashlyn...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
1-15